{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:30:13Z","timestamp":1792801813896,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Research and Development Program of Hubei Province","award":["No.2022BCA007"],"award-info":[{"award-number":["No.2022BCA007"]}]},{"name":"the Knowledge Innovation Program of Wuhan-Shuguang Project","award":["No.2023020201020490"],"award-info":[{"award-number":["No.2023020201020490"]}]},{"name":"the Bethune Charitable Foundation","award":["No.2117"],"award-info":[{"award-number":["No.2117"]}],"id":[{"id":"https:\/\/ror.org\/0430c7a41","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-025-00929-2","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:31:05Z","timestamp":1756459865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Fusion model integrating multi-sequence MRI radiomics and habitat imaging for predicting pathological complete response in breast cancer treated with neoadjuvant therapy"],"prefix":"10.1186","volume":"25","author":[{"given":"Shaojie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"3","key":"929_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"1","key":"929_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13058-015-0642-8","volume":"17","author":"EH Lips","year":"2015","unstructured":"Lips EH, Michaut M, Hoogstraat M, et al. Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response [J]. Breast Cancer Research: BCR. 2015;17(1):134.","journal-title":"Breast Cancer Research: BCR"},{"issue":"16","key":"929_CR3","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy [J]. Clin Cancer Research: Official J Am Association Cancer Res. 2005;11(16):5678\u201385.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"9","key":"929_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jama.293.9.1073","volume":"293","author":"HB Muss","year":"2005","unstructured":"Muss HB, Woolf S, Berry D, et al. Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer [J]. JAMA. 2005;293(9):1073\u201381.","journal-title":"JAMA"},{"key":"929_CR5","doi-asserted-by":"crossref","unstructured":"Qiu J, Zheng Y, Qian D et al. Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data [J]. Journal of oncology, 2022. 2022:6972703.","DOI":"10.1155\/2022\/6972703"},{"key":"929_CR6","doi-asserted-by":"crossref","unstructured":"Lee BM, Cho Y, Kim JW et al. Association between skeletal muscle loss and the response to neoadjuvant chemotherapy for breast cancer [J]. Cancers, 2021, 13(8).","DOI":"10.3390\/cancers13081806"},{"key":"929_CR7","doi-asserted-by":"crossref","unstructured":"Schwartz LH, Liti\u00e8re S, De Vries E et al. RECIST 1.1-Update and clarification: From the RECIST committee [J]. European journal of cancer (Oxford, England: 1990). 2016;62:132-7.","DOI":"10.1016\/j.ejca.2016.03.081"},{"key":"929_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12885-015-1664-4","volume":"15","author":"ML Marinovich","year":"2015","unstructured":"Marinovich ML, Macaskill P, Irwig L, et al. Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis [J]. BMC Cancer. 2015;15:662.","journal-title":"BMC Cancer"},{"key":"929_CR9","doi-asserted-by":"crossref","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R et al. Radiomics: extracting more information from medical images using advanced feature analysis [J]. European journal of cancer (Oxford, England: 1990). 2012;48(4):441-6.","DOI":"10.1016\/j.ejca.2011.11.036"},{"key":"929_CR10","first-page":"l886","volume":"364","author":"DS Watson","year":"2019","unstructured":"Watson DS, Krutzinna J, Bruce IN, et al. Clinical applications of machine learning algorithms: beyond the black box [J]. BMJ (Clinical Res ed). 2019;364:l886.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"6","key":"929_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/joim.12822","volume":"284","author":"GS Handelman","year":"2018","unstructured":"Handelman GS, Kok HK, Chandra RV, et al. eDoctor: machine learning and the future of medicine [J]. J Intern Med. 2018;284(6):603\u201319.","journal-title":"J Intern Med"},{"key":"929_CR12","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3389\/fonc.2020.01410","volume":"10","author":"S Chen","year":"2020","unstructured":"Chen S, Shu Z, Li Y, et al. Machine Learning-Based radiomics nomogram using magnetic resonance images for prediction of neoadjuvant chemotherapy efficacy in breast cancer patients [J]. Front Oncol. 2020;10:1410.","journal-title":"Front Oncol"},{"issue":"16","key":"929_CR13","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1002\/cam4.3255","volume":"9","author":"D Dicenzo","year":"2020","unstructured":"Dicenzo D, Quiaoit K, Fatima K, et al. Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: results from multi-institutional study [J]. Cancer Med. 2020;9(16):5798\u2013806.","journal-title":"Cancer Med"},{"issue":"7","key":"929_CR14","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1007\/s00259-019-04313-8","volume":"46","author":"L Antunovic","year":"2019","unstructured":"Antunovic L, De Sanctis R, Cozzi L, et al. PET\/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy [J]. Eur J Nucl Med Mol Imaging. 2019;46(7):1468\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"929_CR15","doi-asserted-by":"crossref","unstructured":"Jiang M, Li CL, Luo XM et al. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer [J]. European journal of cancer (Oxford, England: 1990). 2021;147:95\u2013105.","DOI":"10.1016\/j.ejca.2021.01.028"},{"key":"929_CR16","doi-asserted-by":"crossref","unstructured":"Tar PD, Thacker NA, Babur M et al. Habitat imaging of tumors enables high confidence Sub-Regional assessment of response to therapy [J]. Cancers, 2022, 14(9).","DOI":"10.3390\/cancers14092159"},{"issue":"9","key":"929_CR17","doi-asserted-by":"publisher","first-page":"e0136557","DOI":"10.1371\/journal.pone.0136557","volume":"10","author":"J Lee","year":"2015","unstructured":"Lee J, Narang S, Martinez J, et al. Spatial habitat features derived from multiparametric magnetic resonance imaging data are associated with molecular subtype and 12-Month survival status in glioblastoma multiforme [J]. PLoS ONE. 2015;10(9):e0136557.","journal-title":"PLoS ONE"},{"issue":"1","key":"929_CR18","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.1038\/s41598-017-09932-5","volume":"7","author":"YC Chang","year":"2017","unstructured":"Chang YC, Ackerstaff E, Tschudi Y, et al. Delineation of tumor habitats based on dynamic contrast enhanced MRI [J]. Sci Rep. 2017;7(1):9746.","journal-title":"Sci Rep"},{"issue":"1","key":"929_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1148\/radiol.13122697","volume":"269","author":"RA Gatenby","year":"2013","unstructured":"Gatenby RA, Grove O, Gillies RJ. Quantitative imaging in cancer evolution and ecology [J]. Radiology. 2013;269(1):8\u201315.","journal-title":"Radiology"},{"issue":"1","key":"929_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1148\/radiol.2018172462","volume":"288","author":"J Wu","year":"2018","unstructured":"Wu J, Cao G, Sun X, et al. Intratumoral Spatial heterogeneity at perfusion MR imaging predicts Recurrence-free survival in locally advanced breast cancer treated with neoadjuvant chemotherapy [J]. Radiology. 2018;288(1):26\u201335.","journal-title":"Radiology"},{"issue":"5","key":"929_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0960-9776(03)00106-1","volume":"12","author":"KN Ogston","year":"2003","unstructured":"Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival [J]. Breast (Edinburgh Scotland). 2003;12(5):320\u20137.","journal-title":"Breast (Edinburgh Scotland)"},{"key":"929_CR22","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) [J]. European journal of cancer (Oxford, England: 1990). 2009;45(2):228\u201347.","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"929_CR23","doi-asserted-by":"crossref","unstructured":"Ten Berge D, Hurkmans DP, Den Besten I, et al. Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis [J]. Volume 5. ERJ open research; 2019. 4.","DOI":"10.1183\/23120541.00179-2019"},{"issue":"17","key":"929_CR24","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1016\/j.ejca.2011.06.012","volume":"47","author":"C Gomez-Roca","year":"2011","unstructured":"Gomez-Roca C, Koscielny S, Ribrag V, et al. Tumour growth rates and RECIST criteria in early drug development [J]. Eur J Cancer (Oxford England: 1990). 2011;47(17):2512\u20136.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"9","key":"929_CR25","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.mri.2013.07.002","volume":"31","author":"RG Abramson","year":"2013","unstructured":"Abramson RG, Li X, Hoyt TL, et al. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results [J]. Magn Reson Imaging. 2013;31(9):1457\u201364.","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"929_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jnci\/djs528","volume":"105","author":"ML Marinovich","year":"2013","unstructured":"Marinovich ML, Houssami N, Macaskill P, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy [J]. J Natl Cancer Inst. 2013;105(5):321\u201333.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"929_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1080\/02841860701373587","volume":"46","author":"HJ Kim","year":"2007","unstructured":"Kim HJ, Im YH, Han BK, et al. Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI [J]. Acta Oncol (Stockholm Sweden). 2007;46(7):996\u20131003.","journal-title":"Acta Oncol (Stockholm Sweden)"},{"issue":"19","key":"929_CR28","doi-asserted-by":"publisher","first-page":"e25908","DOI":"10.1097\/MD.0000000000025908","volume":"100","author":"J Peng","year":"2021","unstructured":"Peng J, Pu H, Jia Y, et al. Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer [J]. Medicine. 2021;100(19):e25908.","journal-title":"Medicine"},{"issue":"1","key":"929_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1148\/radiol.15141625","volume":"277","author":"K Sun","year":"2015","unstructured":"Sun K, Chen X, Chai W, et al. Breast cancer: diffusion kurtosis MR Imaging-Diagnostic accuracy and correlation with Clinical-Pathologic factors [J]. Radiology. 2015;277(1):46\u201355.","journal-title":"Radiology"},{"issue":"1","key":"929_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.31557\/APJCP.2020.21.1.93","volume":"21","author":"N Hulikal","year":"2020","unstructured":"Hulikal N, Gajjala SR, Kalawat T, et al. Predicting response to neoadjuvant chemotherapy using 18F FDG PET-CT in patients with locally advanced breast cancer [J]. Asian Pac J Cancer Prevention: APJCP. 2020;21(1):93\u20138.","journal-title":"Asian Pac J Cancer Prevention: APJCP"},{"issue":"1","key":"929_CR31","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1097\/MJT.0000000000001469","volume":"29","author":"The Value of Ultrasonic Elastography","year":"2022","unstructured":"The Value of Ultrasonic Elastography. Combined with serum ATF5 in predicting the efficacy of Neo-adjuvant chemotherapy in breast cancer: erratum [J]. Am J Ther. 2022;29(1):e162.","journal-title":"Am J Ther"},{"key":"929_CR32","doi-asserted-by":"crossref","unstructured":"Xu Y, Yuan C, Peng J, et al. LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer [J]. Volume 9. Genes & diseases; 2022. pp. 837\u201340. 4.","DOI":"10.1016\/j.gendis.2021.10.001"},{"issue":"5","key":"929_CR33","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1007\/s00259-020-04684-3","volume":"47","author":"P Li","year":"2020","unstructured":"Li P, Wang X, Xu C, et al. (18)F-FDG PET\/CT radiomic predictors of pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer patients [J]. Eur J Nucl Med Mol Imaging. 2020;47(5):1116\u201326.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"929_CR34","first-page":"105","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences [J]. Biochim Biophys Acta. 2010;1805(1):105\u201317.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"929_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies [J]. Nat Reviews Clin Oncol. 2018;15(2):81\u201394.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"2","key":"929_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-14-0990","volume":"21","author":"JP O\u2019connor","year":"2015","unstructured":"O\u2019connor JP, Rose CJ, Waterton JC, et al. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome [J]. Clin Cancer Research: Official J Am Association Cancer Res. 2015;21(2):249\u201357.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"1","key":"929_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13048-021-00941-7","volume":"15","author":"T Wang","year":"2022","unstructured":"Wang T, Wang H, Wang Y, et al. MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols [J]. J Ovarian Res. 2022;15(1):6.","journal-title":"J Ovarian Res"},{"key":"929_CR38","doi-asserted-by":"publisher","first-page":"1046005","DOI":"10.3389\/fonc.2022.1046005","volume":"12","author":"X Gong","year":"2022","unstructured":"Gong X, Guo Y, Zhu T, et al. Diagnostic performance of radiomics in predicting axillary lymph node metastasis in breast cancer: A systematic review and meta-analysis [J]. Front Oncol. 2022;12:1046005.","journal-title":"Front Oncol"},{"key":"929_CR39","doi-asserted-by":"crossref","unstructured":"Choi SW, Cho HH, Koo H et al. Multi-Habitat radiomics unravels distinct phenotypic subtypes of glioblastoma with clinical and genomic significance [J]. Cancers, 2020, 12(7).","DOI":"10.3390\/cancers12071707"},{"key":"929_CR40","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3389\/fonc.2020.01363","volume":"10","author":"Y Han","year":"2020","unstructured":"Han Y, Chai F, Wei J, et al. Identification of predominant histopathological growth patterns of colorectal liver metastasis by Multi-Habitat and Multi-Sequence based radiomics analysis [J]. Front Oncol. 2020;10:1363.","journal-title":"Front Oncol"},{"key":"929_CR41","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fonc.2020.00563","volume":"10","author":"M Fang","year":"2020","unstructured":"Fang M, Kan Y, Dong D, et al. Multi-Habitat based radiomics for the prediction of treatment response to concurrent chemotherapy and radiation therapy in locally advanced cervical cancer [J]. Front Oncol. 2020;10:563.","journal-title":"Front Oncol"},{"key":"929_CR42","doi-asserted-by":"crossref","unstructured":"Wang L, Chen X, Liu Y et al. Multi-modality radiomics model predicts axillary lymph node metastasis of breast cancer using MRI and mammography. Eur Radiol. 2024.","DOI":"10.1007\/s00330-024-10638-2"},{"key":"929_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10549-022-06521-7","volume":"193","author":"L Qi","year":"2022","unstructured":"Qi L, Zhao X, Wang J, et al. Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer. Breast Cancer Res Treat. 2022;193:121\u201338.","journal-title":"Breast Cancer Res Treat"},{"key":"929_CR44","doi-asserted-by":"crossref","unstructured":"Braman N, Etesami M, Prasanna P et al. Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)-positive breast cancer. JAMA Netw Open. 2019.","DOI":"10.1001\/jamanetworkopen.2019.2561"},{"key":"929_CR45","doi-asserted-by":"publisher","first-page":"101899","DOI":"10.1016\/j.eclinm.2023.101899","volume":"58","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhu T, Zhang X, et al. Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study [J]. EClinicalMedicine. 2023;58:101899.","journal-title":"EClinicalMedicine"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-025-00929-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-025-00929-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:34:53Z","timestamp":1757450093000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-025-00929-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["929"],"URL":"https:\/\/doi.org\/10.1186\/s40644-025-00929-2","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a retrospective analysis and has received ethical approval from the Medical Ethics Committee of Huazhong University of Science and Technology Tongji Medical College Affiliated Tongji Hospital (Approval No: TJ-IRB20231173). The study was conducted in strict accordance with the ethical principles outlined in the Declaration of Helsinki. Given the retrospective nature of the study, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}